Is Tenet Healthcare Corp. overvalued or undervalued?

As of 24 October 2025, the valuation grade for Tenet Healthcare Corp. has moved from expensive to fair. Based on the analysis, the company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 10, an EV to EBITDA of 8.89, and a Price to Book Value of 5.79. In comparison, its peer, which has a P/E of approximately 10.41 and an EV to EBITDA of 9.11, suggests that Tenet is in line with industry standards.
Tenet Healthcare Corp. has demonstrated strong performance with a year-to-date return of 66.66%, significantly outperforming the S&P 500's return of 15.47% over the same period. This robust performance reinforces the notion that the stock is fairly valued given its current metrics.